"Spliceosomes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organelles in which the splicing and excision reactions that remove introns from precursor messenger RNA molecules occur. One component of a spliceosome is five small nuclear RNA molecules (U1, U2, U4, U5, U6) that, working in conjunction with proteins, help to fold pieces of RNA into the right shapes and later splice them into the message.
Descriptor ID |
D017381
|
MeSH Number(s) |
A11.284.430.106.279.345.850
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Spliceosomes".
Below are MeSH descriptors whose meaning is more specific than "Spliceosomes".
This graph shows the total number of publications written about "Spliceosomes" by people in this website by year, and whether "Spliceosomes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
1997 | 0 | 1 | 1 |
1998 | 2 | 0 | 2 |
2000 | 0 | 3 | 3 |
2001 | 1 | 1 | 2 |
2002 | 0 | 1 | 1 |
2005 | 1 | 1 | 2 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2012 | 1 | 2 | 3 |
2013 | 1 | 3 | 4 |
2015 | 2 | 1 | 3 |
2016 | 1 | 0 | 1 |
2017 | 2 | 2 | 4 |
2018 | 0 | 2 | 2 |
2019 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
2021 | 3 | 2 | 5 |
2022 | 1 | 2 | 3 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Spliceosomes" by people in Profiles.
-
Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations. Leukemia. 2023 06; 37(6):1397-1400.
-
Dysregulation of global circular RNA abundance regulated by spliceosomes predicts prognosis in hepatocellular carcinoma. Hepatol Commun. 2022 Dec; 6(12):3578-3591.
-
Cwc27, associated with retinal degeneration, functions as a splicing factor in vivo. Hum Mol Genet. 2022 04 22; 31(8):1278-1292.
-
Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Proc Natl Acad Sci U S A. 2022 04 19; 119(16):e2117857119.
-
Splicing is an alternate oncogenic pathway activation mechanism in glioma. Nat Commun. 2022 01 31; 13(1):588.
-
Aberrant RNA methylation triggers recruitment of an alkylation repair complex. Mol Cell. 2021 10 21; 81(20):4228-4242.e8.
-
PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA. J Biol Chem. 2021 07; 297(1):100882.
-
Chromosomal instability by mutations in the novel minor spliceosome component CENATAC. EMBO J. 2021 07 15; 40(14):e106536.
-
Expedient Total Syntheses of Pladienolide-Derived Spliceosome Modulators. J Am Chem Soc. 2021 04 07; 143(13):4915-4920.
-
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. 2021 01 21; 184(2):384-403.e21.